Targeting AQP4 localization as a novel therapeutic target in CNS edema.

Acta Biochim Biophys Sin (Shanghai)

Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, CA 92037, USA.

Published: February 2021

Download full-text PDF

Source
http://dx.doi.org/10.1093/abbs/gmaa158DOI Listing

Publication Analysis

Top Keywords

targeting aqp4
4
aqp4 localization
4
localization novel
4
novel therapeutic
4
therapeutic target
4
target cns
4
cns edema
4
targeting
1
localization
1
novel
1

Similar Publications

Some patients with neuromyelitis optica spectrum disorder (NMOSD)-like symptoms test negative for anti-aquaporin-4 (anti-AQP4) antibodies. Among them, a subset has antibodies targeting myelin oligodendrocyte glycoprotein (MOG), a condition now termed MOG antibody-associated disease (MOGAD). MOGAD shares features with NMOSD, like optic neuritis and myelitis, but differs in pathophysiology, clinical presentation, imaging findings, and biomarkers.

View Article and Find Full Text PDF
Article Synopsis
  • Astrocytes help clear proteins and waste in the brain using aquaporin-4 (AQP4), which can be disrupted in stress-related disorders.
  • Dexamethasone (Dexa), a glucocorticoid used to model stress, was found to reduce the activity of AQP4 and its associated proteins in astrocytes, leading to impaired protein clearance.
  • The study suggests that blocking adenosine A receptors (AR) can restore AQP4 function and clearance, indicating a potential therapeutic strategy to address neurological disorders linked to stress and protein accumulation.
View Article and Find Full Text PDF

Neutrophil Extracellular Traps Induce Brain Edema Around Intracerebral Hematoma via ERK-Mediated Regulation of MMP9 and AQP4.

Transl Stroke Res

December 2024

Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Rd, Yuzhong, Chongqing, 400010, China.

Perihematomal edema (PHE) significantly aggravates secondary brain injury in patients with intracerebral hemorrhage (ICH), yet its detailed mechanisms remain elusive. Neutrophil extracellular traps (NETs) are known to exacerbate neurological deficits and worsen outcomes after stroke. This study explores the potential role of NETs in the pathogenesis of brain edema following ICH.

View Article and Find Full Text PDF

Virus encephalitis (VE), recognized as one of the common kinds of central nervous system (CNS) diseases after virus infection, has a surprising correlation with autoimmune encephalitis (AE) when autoimmune antibodies emerge in cerebrospinal fluid (CSF) or serum. Herpes simplex virus and Epstein-Barr virus are the most critical agents worldwide. By molecular mimicry, herpes viruses can invade the brain directly or indirectly.

View Article and Find Full Text PDF

Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders.

Orphanet J Rare Dis

December 2024

Department of Neurology, The First Affiliated Hospital, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Sun Yat-Sen University, No. 58 Zhongshan Road 2, Guangzhou, 510080, China.

Background: Neuromyelitis Optica Spectrum Disorders (NMOSD) comprise a group of autoimmune-mediated, inflammatory, demyelinating central nervous system diseases caused by aquaporin-4 (AQP4) IgG autoantibodies. Efgartigimod is a human IgG Fc fragment that reduces antibody titers by targeting the neonatal Fc receptor (FcRn). This study documents the efficacy of efgartigimod combined with intravenous methylprednisolone (IVMP) in the acute phase of NMOSD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!